Section 4: Pharmacology of Antibacterial Agents Clinical Implications

$164.00

AGD Member:  114.80

Student Member: 87.50

Speaker:  Geza T. Terezhalmy, DDS, MA

Non-Member: 164.00

Credit Hours:  3.5

Subject Code: 340 – Anesthesia and Pain Management

*AGD Member discount applied at checkout.

SKU: 932 Category:

Description

Course Abstract:

Most odontogenic infections are polymicrobial. The number of isolated strains ranges from 1 to 10 with an average number of approximately 4 isolates per infection. Ultimately, facultative gram-positive and gram-negative cocci and bacilli; and anaerobic gram-positive and gram-negative cocci and bacilli predominate in all types of odontogenic infections. Most odontogenic infections can be resolved satisfactorily through debridement (primary dental care). When antibacterial chemotherapy is indicated, the drug of choice should be either the most effective drug against the infective pathogens or the least toxic alternative among several available agents.

Course Description:

Introduce evidence-based information that will help with the selection of the most appropriate antibacterial agent for the management of an odontogenic infection.

Learning Objectives:

  1. Discuss the etiology of odontogenic infections
  2. Discuss the pharmacology of antibacterial agents
  3. Discuss factors to be considered in the selection of an antibacterial agent
  4. Discuss potential adverse drug events associated with the use of antibacterial agents

 

Dr. Geza T. Terezhalmy received his D.D.S. degree from Case Western Reserve School of Dental Medicine and his M.A. from The George Washington University. Currently he is a professor for the Department of Comprehensive Dentistry at the University of Texas Health Science Center at the San Antonio Dental School. He is also a clinical professor for the Department of Pharmacology at the Graduate School of Biomedical Sciences at the University of Texas Health Science Center at the San Antonio Dental School. Dr. Terezhalmy serves as a National Consultant for Dental Pharmacotherapeutics to the US Surgeon General and also to the Naval Postgraduate Dental School as a consultant in their department of Oral Medicine. He has served on the editorial boards of Quintessence International, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology and has an extensive list of publication credits with articles appearing in The American Journal of Dentistry, The International Journal of Dental Hygiene, the Journal of Contemporary Dental Practice and the Archives of Oral Biology. Dr. Terezhalmy has served as president of the Organization of Teachers of Oral Diagnosis and of the American Academy of Oral Medicine.

Additional information

Expiration Date

October 23, 2021

Reviews

There are no reviews yet.

Be the first to review “Section 4: Pharmacology of Antibacterial Agents Clinical Implications”
<